
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $48.9M | $43.2M | $51.4M | $59.5M | $58.3M | |
Revenue Growth (YoY) | -- | -11.68% | 19.03% | 15.7% | -2% | |
Cost of Revenues | $41.2M | $35.3M | $42.2M | $48.6M | $47.4M | |
Gross Profit | $7.7M | $8M | $9.3M | $10.9M | $10.9M | |
Gross Profit Margin | 15.83% | 18.4% | 18.04% | 18.33% | 18.73% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $6.7M | $6.6M | $7.7M | $7.9M | $9.6M | |
Other Inc / (Exp) | $228K | $660K | $795K | $333K | $507K | |
Operating Expenses | $6.1M | $6.7M | $7.6M | $8.3M | $10.1M | |
Operating Income | $1.6M | $1.3M | $1.7M | $2.6M | $852K | |
Net Interest Expenses | $767K | $539K | $632K | $1M | $1.2M | |
EBT. Incl. Unusual Items | $1.1M | $1.4M | $1.9M | $1.9M | $117K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $127K | $8K | $325K | $275K | $109K | |
Net Income to Company | $972K | $1.4M | $1.5M | $1.6M | $8K | |
Minority Interest in Earnings | -- | -- | -$77K | -$79K | -- | |
Net Income to Common Excl Extra Items | $972K | $1.4M | $1.5M | $1.6M | $8K | |
Basic EPS (Cont. Ops) | $0.08 | $0.11 | $0.15 | $0.16 | $0.00 | |
Diluted EPS (Cont. Ops) | $0.08 | $0.11 | $0.12 | $0.13 | $0.00 | |
Weighted Average Basic Share | $12.5M | $12.5M | $9.9M | $9.9M | $9.9M | |
Weighted Average Diluted Share | $12.5M | $12.5M | $12.5M | $12.5M | $9.9M | |
EBITDA | $2.4M | $2.2M | $2.7M | $3.4M | $1.9M | |
EBIT | $1.9M | $1.9M | $2.5M | $2.9M | $1.4M | |
Revenue (Reported) | $48.9M | $43.2M | $51.4M | $59.5M | $58.3M | |
Operating Income (Reported) | $1.6M | $1.3M | $1.7M | $2.6M | $852K | |
Operating Income (Adjusted) | $1.9M | $1.9M | $2.5M | $2.9M | $1.4M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $43.2M | $51.4M | $59.5M | $58.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $35.3M | $42.2M | $48.6M | $47.4M | |
Gross Profit | -- | $8M | $9.3M | $10.9M | $10.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $6.6M | $7.7M | $7.9M | $9.6M | |
Other Inc / (Exp) | -- | $660K | $795K | $333K | $507K | |
Operating Expenses | -- | $6.7M | $7.6M | $8.3M | $10.1M | |
Operating Income | -- | $1.3M | $1.7M | $2.6M | $852K | |
Net Interest Expenses | -- | $539K | $632K | $1M | $1.2M | |
EBT. Incl. Unusual Items | -- | $1.4M | $1.9M | $1.9M | $117K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $8K | $325K | $275K | $109K | |
Net Income to Company | -- | $1.4M | $1.5M | $1.6M | $8K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | $1.4M | $1.5M | $1.6M | $8K | |
Basic EPS (Cont. Ops) | -- | $0.14 | $0.15 | $0.17 | $0.00 | |
Diluted EPS (Cont. Ops) | -- | $0.11 | $0.12 | $0.13 | -$0.03 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | $2.2M | $2.7M | $3.4M | $1.9M | |
EBIT | -- | $1.9M | $2.5M | $2.9M | $1.4M | |
Revenue (Reported) | -- | $43.2M | $51.4M | $59.5M | $58.3M | |
Operating Income (Reported) | -- | $1.3M | $1.7M | $2.6M | $852K | |
Operating Income (Adjusted) | -- | $1.9M | $2.5M | $2.9M | $1.4M |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2.3M | $1.1M | $919K | $690K | $1.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $16.6M | $14.9M | $16.2M | $14.6M | $13.2M | |
Inventory | $15.4M | $15.3M | $18.8M | $19M | $18.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $39.5M | $34M | $39.6M | $37.6M | $36.8M | |
Property Plant And Equipment | $620K | $430K | $702K | $1.5M | $1.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $209K | -- | -- | -- | -- | |
Total Assets | $40.3M | $34.4M | $40.3M | $39.1M | $39.6M | |
Accounts Payable | $2.7M | $2.5M | $5M | $4.6M | $4.6M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $16M | $12.5M | $15.9M | $15.8M | $18M | |
Current Portion Of Capital Lease Obligations | $150K | $118K | $204K | $422K | $365K | |
Other Current Liabilities | -- | -- | -- | -$1K | -- | |
Total Current Liabilities | $22.6M | $30M | $36.9M | $34.5M | $28.6M | |
Long-Term Debt | $3.5M | $2.8M | $1.8M | $991K | $1.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $26.5M | $33.1M | $39M | $36M | $30.7M | |
Common Stock | $9K | $9K | $5K | $5K | $5K | |
Other Common Equity Adj | $220K | -$90K | -$72K | -$1K | -$127K | |
Common Equity | $13.8M | $1.3M | $1.3M | $3.1M | $8.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $77K | -- | -- | |
Total Equity | $13.8M | $1.3M | $1.4M | $3.1M | $8.9M | |
Total Liabilities and Equity | $40.3M | $34.4M | $40.3M | $39.1M | $39.6M | |
Cash and Short Terms | $2.3M | $1.1M | $919K | $690K | $1.7M | |
Total Debt | $19.5M | $15.3M | $17.7M | $16.8M | $19.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $1.1M | $919K | $690K | $1.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | $14.9M | $16.2M | $14.6M | $13.2M | |
Inventory | -- | $15.3M | $18.8M | $19M | $18.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | $34M | $39.6M | $37.6M | $36.8M | |
Property Plant And Equipment | -- | $430K | $702K | $1.5M | $1.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | $34.4M | $40.3M | $39.1M | $39.6M | |
Accounts Payable | -- | $2.5M | $5M | $4.6M | $4.6M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | $12.5M | $15.9M | $15.8M | $18M | |
Current Portion Of Capital Lease Obligations | -- | $118K | $204K | $422K | $365K | |
Other Current Liabilities | -- | -- | -- | -$1K | -- | |
Total Current Liabilities | -- | $30M | $36.9M | $34.5M | $28.6M | |
Long-Term Debt | -- | $2.8M | $1.8M | $991K | $1.9M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $33.1M | $39M | $36M | $30.7M | |
Common Stock | -- | $9K | $5K | $5K | $5K | |
Other Common Equity Adj | -- | -$90K | -$72K | -$1K | -$127K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $77K | -- | -- | |
Total Equity | -- | $1.3M | $1.4M | $3.1M | $8.9M | |
Total Liabilities and Equity | -- | $34.4M | $40.3M | $39.1M | $39.6M | |
Cash and Short Terms | -- | $1.1M | $919K | $690K | $1.7M | |
Total Debt | -- | $15.3M | $17.7M | $16.8M | $19.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $972K | $1.4M | $1.5M | $1.6M | $8K | |
Depreciation & Amoritzation | $523K | $238K | $256K | $471K | $573K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $3.6M | $1.7M | -$3.8M | $1.7M | -$691K | |
Change in Inventories | -$949K | $126K | -$3.5M | -$5K | $844K | |
Cash From Operations | $3M | $3.1M | -$2.1M | $1.6M | $2.7M | |
Capital Expenditures | $230K | $32K | $283K | $455K | $774K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$222K | -$30K | -$283K | -$455K | -$774K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$2.4M | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$2.5M | -$4.4M | -$182K | -$272K | -$402K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $206K | $312K | -- | -- | -$9.2M | |
Cash From Financing | -$2.3M | -$4.1M | $2.1M | -$1.5M | -$568K | |
Beginning Cash (CF) | $1.9M | $2.7M | $1.5M | $1.3M | $987K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $550K | -$968K | -$200K | -$388K | $1.3M | |
Ending Cash (CF) | $2.7M | $1.5M | $1.3M | $987K | $2M | |
Levered Free Cash Flow | $2.8M | $3.1M | -$2.3M | $1.2M | $1.9M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $1.4M | $1.5M | $1.6M | $8K | |
Depreciation & Amoritzation | -- | $238K | $256K | $471K | $573K | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | $1.7M | -$3.8M | $1.7M | -$691K | |
Change in Inventories | -- | $126K | -$3.5M | -$5K | $844K | |
Cash From Operations | -- | $3.1M | -$2.1M | $1.6M | $2.7M | |
Capital Expenditures | -- | -- | $283K | $455K | $774K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$30K | -$283K | -$455K | -$774K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$1.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$4.4M | -$182K | -$272K | -$402K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -$4.1M | $2.1M | -$1.5M | -$568K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$1M | -$106.5K | -$244K | $1.3M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | $3.1M | -$2.3M | $1.2M | $1.9M |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.